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Abstract
Background: This study investigated if the H. pylori dupA genotype and certain host single nucleotide
polymorphisms (SNPs) of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs), including MMP-3, MMP-7,
MMP-9, TIMP-1 and TIMP-2, might correlate with ulcer risk of H. pylori-infected Taiwanese patients.
Results: Of the 549 H. pylori-infected patients enrolled, 470 patients (265 with gastritis, 118 with duodenal ulcer,
and 87 with gastric ulcer) received SNPs analysis of MMP-3-1612 6A > 5A, MMP-7-181 A > G, MMP-9exon 6 A > G, TIMP-
1372 T > C and TIMP-2-418 G > C by PCR-RFLP. The 181 collected H. pylori isolates were detected for the dupA
genotype by PCR. The rates of dupA-positive H. pylori infection were similar among patients with duodenal ulcer
(22.8%), gastric ulcer (20.0%), and gastritis (25.5%) (p > 0.05). Males had higher rates of duodenal ulcer and gastric
ulcer than females (p < 0.01). Of H. pylori-infected patients, the MMP-3 6A6A genotype were more common in
patients with duodenal ulcers than in those with gastritis (87.7% vs. 74.9%, p < 0.05) in females. This genotype had
a 2.4-fold (95% CI: 1.02-5.66) increased risk of duodenal ulcer, compared to those with the 5A carrier. Combining
the MMP-3/TIMP-1 genotype as 6A6A/CC, the risk of duodenal ulcer increased up to 3.6 fold (p < 0.05) in
H. pylori-infected females.
Conclusions: The MMP-3 promoter polymorphism, but not the dupA-status, may correlate with susceptibility to
duodenal ulcer after H. pylori infection in Taiwanese females.
Background
Helicobacter pylori infection leads to chronic gastritis and
in some individuals, to peptic ulcer disease or even gastric
carcinoma [1]. Diverse outcomes may depend on complex
interactions among bacterial virulence factors, host genet-
ics, and environmental factors [2,3]. In Taiwan, despite the
nearly 100% prevalence of the so-called triple-genopositive
cagA-vacA-babA2 virulent H. pylori infections, there is a
lack of correlation to different disease outcomes [4,5]. It
will be useful for Taiwan to validate new virulence factors
or any host genomic predisposition in relation to severe
H. pylori-infected clinical outcomes.
Recently, a duodenal ulcer-promoting gene A (dupA)
encompassing jhp0917 and jhp0918 has been suggested
to lead into higher IL-8 production of epithelial cells
and thus, triggering dense neutrophil infiltration and
increased risk of duodenal ulcers 2[6]. However, even in
such large-scale validation, those with duodenal ulcer
h a v ean e a r l y5 5 %dupA-positive infection [6]. More-
over, prevalence of dupA and relationships between
dupA-positive H. pylori and clinical outcomes are differ-
e n ti nd i s t i n c tp o p u l a t i o n s[ 7 - 1 1 ] .I tm a yi n d i c a t et h a t
dupA serves a promoting role leading to duodenal ulcer
after H. pylori infection. Alternatively, it is necessary to
validate host factors that predispose patients to gastro-
duodenal ulcer, especially with dupA-negative infection.
H. pylori infection stimulates the production of pro-
inflammatory cytokines, such as IL-1, which play impor-
tant roles in gastric inflammation and physiology. How-
ever, IL-1 beta or IL-1RN polymorphisms are not
associated with gastric ulcer in the Taiwanese popula-
tion [12].
Matrix metalloproteinases (MMPs) are a family of
enzymes that degrade most extracellular matrix and
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any medium, provided the original work is properly cited.correlate with ulcer formation or repairs [13]. H. pylori
infection can up-regulate MMP-3, MMP-7, and MMP-9
in the gastric mucosa and even sera [14-16]. A large-
scale German survey has further validated that the
single-nucleotide polymorphisms (SNP) genotype as
MMP-7-181 G allele and MMP-9exon 6 A allele increase
the risk of gastric ulcer after H. pylori infection [17].
A deletion at MMP-3 promoter -1612, and A to G sub-
stitution at MMP-7 promoter -181 may affect transcrip-
tional activity, leading to alterations in gene expression
[18,19]. Moreover, A to G substitution at MMP-9 exon
6 causes the amino acid change required for binding to
its substrate and affects its binding ability [20].
Although MMP activity is in general counteracted by
endogenous tissue inhibitors (TIMPs) [21], there
remains no data to check whether TIMP-1 and TIMP-2
SNP genotypes relate to the risk of gastroduodenal ulcer
after H. pylori-infection. As such, this study surveyed if
the H. pylori dupA genotype and certain SNP genotypes
of MMP-3, MMP-7, MMP-9, TIMP-1, and TIMP-2 pre-
dispose H. pylori-infected Taiwanese patients to ulcer
risks.
Methods
Patients and study design
Five hundred and forty-nine consecutive H. pylori-
infected patients documented by upper gastrointestinal
endoscopy at National Cheng Kung University Medical
Center, Tainan, Taiwan were enrolled. All were geneti-
cally unrelated ethnic Han Chinese from Tainan City and
the surrounding regions. None had been treated with
NSAIDs, proton pump inhibitor, or any antibiotics within
two weeks prior to panendoscopy on enrollment, or a
past history of anti-H. pylori treatment and peptic ulcer.
The hospital Ethics Committee approved the study.
After obtaining informed consent, 470 patients had pro-
vided enough blood samplings for SNPs analysis of MMP-
3-1612 6A > 5A,M M P - 7 -181 A > G,M M P - 9 exon 6 A > G,
TIMP-1372 T > C and TIMP-2-418 G > C by PCR-RFLP.
A s i d ef r o me n d o s c o p i cd i a g n o s is for clinical diseases, at
least three topographic gastric biopsies were sampled for
histology or H. pylori culture, one each from the antrum,
corpus, and cardia. These were stained with haematoxylin
and eosin and reviewed for the H. pylori-related histology
by the updated Sydney’s system [4,22,23].
In addition, the study collected 181 H. pylori isolates
for the detection of dupA genotype by PCR. One hun-
dred and three isolates were collected from randomly
selected patients who had agreed to undergo SNP analy-
sis, while 78 isolates were from patients without SNP
analysis. The H. pylori culture were conducted from the
two additional gastric biopsies collected during the same
endoscopy and processed with the method applied in
previous publications [4,22].
For those with positive H. pylori culture, the isolates
were extracted for genomic DNA to be analyzed for the
dupA genotypes by PCR. The extraction of DNA was
done with the same method as described previously
[4,22]. Positive H. pylori infection was defined by posi-
tive histology or culture.
Genotypes of SNPs in MMPs and TIMPs
Peripheral blood 8 ml was obtained from each subject
for genomic DNA, which was extracted from peripheral
blood mononuclear cells according to the manufac-
turer’s instructions (Viogene, Taipei, Taiwan). Five SNPs
in MMP-3-1612 5A/6A, MMP-7-181 A/G, MMP-9exon 6 A/G,
TIMP-1372 C/T,a n dT I M P - 2 -418 G/C polymorphisms
were determined by PCR-RFLP assays [18,24-26].
Using the extracted DNA as template, the regions of
each MMP and TIMP were amplified by PCR using com-
mercially available kits (GoTaq® Green Master Mix, Pro-
m e g a ,M a d i s o n ,W I ,U S A )f o l l o w i n gt h em a n u f a c t u r e r ’s
instructions. The sequences of primers, PCR conditions,
and restriction enzymes (obtained from New England
Biosciences, U.S.) used were summarized in Table 1.
After digestion, the products were separated by electro-
phoresis on a 4% agarose gel. The MMP and TIMP geno-
types were shown as different gel examples (Figure 1).
Quality control for genotyping was achieved by
including in each amplification a negative PCR control
sample and three positive control samples for each SNP
analyzed (homozygous for allele 1, heterozygous, and
homozygous for allele 2). At least 10% of the samples
were run twice in separate assays to reveal 100% concor-
dance of the genotype designation for all of the poly-
morphisms. For the positive controls, the genopositive
products were confirmed by direct sequencing.
Detection of dupA gene by PCR
The dupA-positive H. pylori was determined by positive
PCR amplifications of at least 2 regions (jhp0917 and
jhp0918) of the gene using two specific primer pairs
(Figure 2) for strains J99 and 26695 as templates (Table
1) [6]. DNA 2 μl were added to 50-μl reaction mixture,
containing 1 × PCR buffer, 1.5 mM MgCl2,0 . 2m M
dNTP (Protech, Taiwan), 0.2 μM primers and 1 U Taq
DNA polymerase (Fermentas, USA). PCR was performed
with a thermal cycler (2720 thermal cycler; Applied Bio-
systems). The mixture was stored at 4°C and the PCR
products were separated by electrophoresis on 2% agar-
ose gel. The gels were stained with ethidium bromide
and visualized under UV illumination.
Statistical analysis
Statistical analysis was performed with the SPSS software
(SPSS 12, Chicago, IL, USA). The c
2 test, Fisher’se x a c t
test or Mann-Whitney U test were used as appropriate to
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or SNP genotypes of MMPs and TIMPs between patients
with and those without ulcers. A p <0 . 0 5w a st a k e na s
significant. All test significances were validated by two-
tailed analysis. The odds ratios (OR) and 95% confidence
intervals (CI) were used to estimate the risk to get gastro-
duodenal ulcer in these H. pylori-infected subjects.
Results
Demographic features of the study subjects
Of the 470 H. pylori-positive dyspeptic patients who pro-
vided blood samples for SNP analysis, 276 were females
and 194 males, with median age of 47.2 years (range, 16-
87 years). Endoscopic diagnoses included 265 with gastri-
tis, 118 with duodenal ulcers, and 87 with gastric ulcers.
Their demographics and histology after H. pylori infec-
tion were listed in Table 2. Patients with gastritis and
duodenal ulcer had higher gastric inflammation in the
antrum than those with gastric ulcers (p < 0.05). Among
H. pylori-infected patients, males had higher rates of duo-
denal and gastric ulcers than females (51.7% vs. 30.9%
and 58.6% vs. 30.9%, p < 0.001, respectively).
Prevalence of dupA H. pylori infection in patients
One hundred and eighty-one H. pylori strains were suc-
cessfully obtained (Figure 3). The concordance of two
PCR primer pairs was 95.3% (41/43). Only two isolates
were dupA- p o s i t i v eb ys i n g l ep r i m e rp a i r s .F o r t y - t h r e e
isolates (23.8%) were genopositive for dupA,o fw h i c h
six (20.0%) were from patients with gastric ulcer,
13 (22.8%) from patients with duodenal ulcer, and
24 (25.5%) from gastritis patients. The prevalence rates
of dupA-positive H. pylori infection were similar
between patients with and those without ulcers
(p > 0.05).
MMP and TIMP genotypes and the H. pylori-related
gastro-duodenal ulcer
The 470 H. pylori-infected patients with SNP analysis
had > 99% average genotyping success and the distribu-
tions of all SNPs were in Hardy-Weinberg equilibrium
(p > 0.05). Since the ulcer rate had gender differences
(Table 2), five genotype distributions were analyzed and
separated by gender. There were no significant differ-
ences in genotype distributions of MMP-7-181 A/G,
MMP-9exon 6 A/G,T I M P - 1 372 T/C and TIMP-2-418 G/C
between patients with different clinical diagnoses
(p > 0.05) (Table 3).
There was a higher rate of MMP-3 6A6A genotype in
patients with duodenal ulcers than in patients with gas-
tritis (87.7% vs. 74.9%, p < 0.05). H. pylori-infected sub-
jects with the MMP-3 6A6A genotype had a 2.4-fold
Table 1 The PCR primers used in the study
SNP/gene Primer sequence (5’ ®3’) Size (bp) Restriction enzyme Reference
MMP-3-1612 5A/6A GATTACAGACATGGGTCACG 120 Xmn I Shibata et al, 2005
TTTCAATCAGGACAAGACGAAGTTT 6A: 120 bp
5A: 97 bp + 23 bp
MMP-7-181 A/G TGGTACCATAATGTCCTGAAT 150 EcoR I Jormsjö et al, 2001
TCGTTATTGGCAGGAAGCACACAATGAATT A: 150 bp
G: 120 bp + 30 bp
MMP-9exon6 A/G CCATCCATGGGTCAAAGAAC 295 Sma I Shibata et al, 2005 *
GGGCTGAACCTGGTAGACAG A: 295 bp
G: 192 bp + 103 bp
TIMP-1 372 C/T GCACATCACTACCTGCAGTC 175 BssSI Wollmer et al, 2002
GAAACAAGCCCACGATTTAG T: 175 bp
C: 152 bp + 23 bp
TIMP-2 -418 G/C CGTCTCTTGTTGGCTGGTCA 304 BsoBI Zhou et al, 2004
CCTTCAGCTCGACTCTGGAG C: 253 bp + 51 bp
G: 230 bp + 51 bp + 23 bp
jhp0917_1 TGGTTTCTACTGACAGAGCGC 307 - Lu et al., 2005
jhp0917_2 AACACGCTGACAGGACAATCTCCC
jhp0917_3 GCCTAAGACCTCAAACTAGC 296 - This study *
jhp0917_4 CATTCTGTCAAGAGCTACC
jhp0918_1 CCTATATCGCTAACGCGCGCTC 276 - Lu et al.,
jhp0918_2 AAGCTGAAGCGTTTGTAACG 2005
jhp0918_3 GCTAGAAAGATCAACGGAAC 216 - This study *
jhp0918_4 CACTTGTCTGGCTCTCAT
*The primers were self-designed by applying Primer 3 and the restriction enzyme was selected based on the reference of Shibata et al, 2005.
Yeh et al. BMC Microbiology 2010, 10:218
http://www.biomedcentral.com/1471-2180/10/218
Page 3 of 8(95% CI: 1.02-5.66) increased risk of duodenal ulcer in
females compared to those with the 5A carrier. Because
TIMP-1 genotypes modulated MMP-3 activity, it was
further tested whether the MMP-3-1612/TIMP-1372
Combined genotypes contributed to increased risk of
duodenal ulcers in females. The combined MMP-3/
TIMP-1 genotype as 6A6A/CC had a 3.6-fold (p <0 . 0 5 )
increased risk of duodenal ulcer in H. pylori-infected
female (Table 4).
Discussion
This study surveyed whether the bacterial factor dupA
in H. pylori or single nucleotide polymorphisms of
MMPs and TIMPs correlated with the susceptibility of
gastroduodenal ulcers after H. pylori infection. It shows
a rather low prevalence (23.8%) of dupA-positive
H. pylori infection in Taiwan. Moreover, such a low pre-
valence limits its association to susceptibility to gastro-
duodenal ulcers after H. pylori infection.
The negative finding is consistent with several studies
worldwide [8,10,11] but differs from Lu et al., who sup-
port the promoting role of H. pylori dupA [6]. In their
positive report [6], dupA-positive prevalence is nearly
50% and it can be attributed as the promoting role of
ulceration. Their data suggest that there should be some
other bacterial virulence factor of H. pylori as CagA,
babA2, vacA, or host factors, which determine the sus-
ceptibility of ulceration. In Taiwan, there is nearly a
100% prevalence of CagA, babA2, vacA triple-positive
infection [4,15]. The current study area should be a
good place to validate the host factor predisposing to
ulcer risk.
In the in vitro promoter functional assay of fibroblasts
and vascular smooth muscle cells, the MMP-3 -1612 as
5A allele has greater promoter activities than the 6A
allele [19]. This implies that patients carrying the lower
promoter activity genotype 6A6A in the MMP-3 promo-
ter are accompanied by lower MMP-3 expressions of the
Figure 1 MMP and TIMP genotyping were done by PCR-RFLP and visualized by electrophoresis on 4% agarose gel. The listed genotype
patterns were (A) for MMP-3 -1612 as 5A5A or 6A6A; (B) for MMP-7 -181 as AA, AG, or GG; (C) for MMP-9 exon 6 as AA, AG, or GG; (D) for
TIMP-1 372; as CC, TC, or TT; and (E) for TIMP-2 -418 as CG or GG.
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MMP-3 -1612 as 6A6A, which expresses lower MMP-3
carries a 2.4-fold risk of having duodenal ulcers among
females after H. pylori infection (p < 0.05) (Table 3).
Moreover, TIMP-1 372, as CC, contributes a higher risk
of duodenal ulcers to MMP-3 -1612 6A6A (Table 4).
This data suggests that patients with higher MMP-3
expression may have lower ulcer risk, but the reasons
remain uncertain.
I ng e n e r a l ,M M P - 3c a nd e g r a d eaw i d er a n g eo fs u b -
strates, including fibronectin, type IV, V, IX, and X
collagens, elastin, laminins, gelatin, and proteoglycan
core proteins, and is thus helpful during wound healing
of the skin [27-29]. Moreover, the gastric mucosa at the
ulcer site also has significantly higher expression of
MMP-3 than those in the antrum [30], which suggests
MMP-3 is abundant in the ulcer part, and this may help
the process of re-epithelialization and contribute to
wound healing.
Hellmig et al. disclose the positive associations of
MMP-7 promoter -181 and MMP-9 exon 6 SNPs to the
presence of gastric ulcer among Germans [17]. However,
Figure 2 The sites of primer pairs for PCR on the dupA regions, including for the jhp0917 and the jhp0918 regions, applying the
standard H. pylori isolates (J99) as reference.
Table 2 Demographic and histologic characteristics of H. pylori-infected patients with single nucleotide polymorphism
analysis (n = 470)
Gastritis Duodenal ulcer Gastric ulcer p value
Parameters (n = 265) (n = 118) (n = 87)
Age, mean (SD) (yr) 46.9 (13.7) 47.6 (14.0) 47.8 (11.7) NS
Gender, n (%)
Female: Male 183 (69.1): 82 (30.9) 57 (48.3) : 61 (51.7) 36 (41.4) : 51 (58.6) p
a < 0.05; p
b < 0.05
Histology score, mean (SD)
(Antrum)
AIS (range 1-3) 1.18 (0.99) 1.39 (0.95) 0.99 (1.03) p
c < 0.05
CIS (range 0-3) 2.34 (1.01) 2.56 (0.89) 2.05 (1.17) p
a < 0.05; p
b < 0.05; p
c < 0.05
(Corpus)
AIS (range 1-3) 0.85 (0.99) 0.72 (0.95) 0.86 (1.06) NS
CIS (range 0-3) 2.24 (0.86) 2.15 (0.83) 2.13 (0.89) NS
Abbreviations: AIS, acute inflammation; CIS, chronic inflammation. The p value was determined by t test (age), c
2 test (gender) or Mann-Whitney U test (histology
score).
a indicated significance with p < 0.05 of such parameter between gastritis and duodenal ulcer;
b between gastritis and gastric ulcer;
c between duodenal
ulcer and gastric ulcer. NS: no significant difference.
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and such positive linkage is not disclosed in the current
study from Taiwan.
This is the first report to show that there is no direct
association between the genotypes of TIMP-1 372 at
exon 5 and TIMP-2 at promoter -418, and the presence
of gastroduodenal ulcers (Table 3). However, because
TIMP-1 genotypes may modulate MMP-3 activity,
further testing if the MMP-3-1612 /TIMP-1372 Combined
genotypes contribute to increased risk of duodenal
ulcers shows that the combined MMP-3/TIMP-1 geno-
type as 6A6A/CC has a 3.6-fold increased risk of duode-
nal ulcer (p <0 . 0 5 )i nH. pylori-infected females. This
data suggests that TIMP-1 may also have a supportive
role in interacting with MMP-3 during ulcerogenesis by
H. pylori infection, especially in females.
Figure 3 The study patients and their H. pylori-dupA status.
Table 3 The SNP genotypes of MMPs and TIMPs in the both genders with different clinical diagnoses
Genotype Female Male
N (%) Gastritis DU GU P
a P
b Gastritis DU GU P
a P
b
MMP-3
5A carrier 46 (25.1) 7 (12.3) 8 (22.2) 0.04 0.71 28 (34.1) 15 (24.6) 11 (21.6) 0.22 0.12
6A/6
a 137 (74.9) 50 (87.7) 28 (77.8) 54 (65.9) 46 (75.4) 40 (78.4)
MMP-7
A/A 150 (82.9) 45 (80.4) 32 (91.4) 0.31 72 (88.9) 52 (86.7) 39 (76.5) 0.69 0.06
G carrier 31 (17.1) 11 (19.6) 3 (8.6) 0.67 9 (11.1) 8 (13.3) 12 (23.5)
MMP-9
A carrier 78 (42.6) 19 (33.3) 15 (41.7) 0.21 0.92 25 (30.5) 22 (36.1) 22 (43.1) 0.48 0.14
G/G 105 (57.4) 38 (66.7) 21 (58.3) 57 (69.5) 39 (63.9) 29 (56.9)
TIMP-1
♀ T carrier ♂ T 148 (80.9) 41 (73.2) 29 (80.6) 0.22 0.97 46 (56.8) 31 (50.8) 26 (51.0) 0.48 0.51
C/C C 35 (19.1) 15 (26.8) 7 (19.4) 35 (43.2) 30 (49.2) 25 (49.0)
TIMP-2
C carrier 54 (30.2) 17 (32.1) 10 (28.6) 0.79 0.85 27 (33.3) 20 (32.3) 13 (25.5) 0.89 0.34
G/G 125 (69.8) 36 (67.9) 25 (71.4) 54 (66.7) 42 (67.7) 38 (74.5)
Abbreviations: DU, duodenal ulcer; GU, gastric ulcer. The p value was determined by Fisher’s exact test or c
2 test.
a indicated significance with p < 0.05 of such
parameter between gastritis and duodenal ulcer;
b between gastritis and gastric ulcer. Genotype distribution of SNP in cases and control was in Hardy-Weinberg
equilibrium (p < 0.05).
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MMP-3/TIMP-1 genotype as 6A6A/CC has just an
increased risk of duodenal ulcer in H. pylori-infected
females, but not in male, remains uncertain. If such a
regulation between MMP-3 and TIMP-1 play a role in
female’s ulceration, our data at least imply some other
host or environment factors in male should be more
dominant than such combined genotype.
The study has a limitation of just providing 181 iso-
lates for the analysis of the dupA status of H. pylori,
which disclose a rather low 20% dupA-positive preva-
lence rate. Accordingly, the study became limited to
only 103 patients to provide both analyses on the
infected isolate’s dupA status and the host’sS N P s( F i g -
ure 2). It thus cannot provide an adequate statistical
power to determine the exact impact of MMP-3 SNPs
under dupA-negative specific conditions.
Conclusions
In conclusion, this study provides evidence that host
promoter polymorphisms of MMP-3 contribute to
increased individual susceptibility to duodenal ulcers in
females after H. pylori infection in Taiwan. The MMP-3
promoter genotypes may serve to screen out patients at
risk and target for H. pylori eradication in order to stop
the ulceration process among H. pylori-infected patients
without ulcers yet.
Acknowledgements
This study was supported by grants from the National Science Council,
Taiwan (95-2314-B-006-029-MY3 and 98-2628-B-006-013-MY3), NHRI-EX99-
9908BI from the National Health Research Institute, and DOH99-TD-C-111-
003 from Department of Health, Taiwan. The authors also thank Miss Hunt-
Wen Wu for her assistance.
Author details
1Institute of Basic Medical Sciences, National Cheng Kung University Hospital,
Medical College, Tainan.
2Institute of Clinical Medicine, National Cheng Kung
University Hospital, Medical College, Tainan.
3Department of Internal
Medicine, National Cheng Kung University Hospital, Medical College, Tainan.
4Department of Pathology, National Cheng Kung University Hospital, Medical
College, Tainan.
5Department of Pathology, Ton-Yen General Hospital, Hsin-
Chu, Taiwan.
Authors’ contributions
YCY prepared the manuscript, and carried out the molecular genetic studies
to the host SNPs and dupA genotyping for the collected isolates of H. pylori.
HCC and WLC carried out the SNP analysis and clinical specimen collection
during endoscopy. HBY participated in the design of the study, performed
the analysis of pathology, and statistical analysis. BSS conceived of the
whole study, and participated in its design and coordination. All authors
read and approved the final manuscript.
Received: 24 March 2010 Accepted: 13 August 2010
Published: 13 August 2010
References
1. Labigne A, de Reuse H: Determinants of Helicobacter pylori pathogenicity.
Infect Agents Dis 1996, 5(4):191-202.
2. Maeda S, Mentis AF: Pathogenesis of Helicobacter pylori infection.
Helicobacter 2007, 12(Suppl 1):10-14.
3. Prinz C, Schwendy S, Voland P: H. pylori and gastric cancer: shifting the
global burden. World J Gastroenterol 2006, 12(34):5458-5464.
4. Sheu BS, Odenbreit S, Hung KH, Liu CP, Sheu SM, Yang HB, Wu JJ:
Interaction between host gastric Sialyl-Lewis X and H. pylori SabA
enhances H. pylori density in patients lacking gastric Lewis B antigen.
Am J Gastroenterol 2006, 101(1):36-44.
5. Lai CH, Kuo CH, Chen YC, Chao FY, Poon SK, Chang CS, Wang WC: High
prevalence of cagA-a n dbabA2-positive Helicobacter pylori clinical
isolates in Taiwan. J Clin Microbiol 2002, 40(10):3860-3862.
6. Lu H, Hsu PI, Graham DY, Yamaoka Y: Duodenal ulcer promoting gene of
Helicobacter pylori. Gastroenterology 2005, 128(4):833-848.
7. Schmidt HM, Andres S, Nilsson C, Kovach Z, Kaakoush NO, Engstrand L,
Goh KL, Fock KM, Forman D, Mitchell H: The cag PAI is intact and
functional but HP0521 varies significantly in Helicobacter pylori isolates
from Malaysia and Singapore. Eur J Clin Microbiol Infect Dis 2010,
29(4):439-451.
8. Nguyen LT, Uchida T, Tsukamoto Y, Kuroda A, Okimoto T, Kodama M,
Murakami K, Fujioka T, Moriyama M: Helicobacter pylori dupA gene is not
associated with clinical outcomes in the Japanese population. Clin
Microbiol Infect 2010, 16(8):1264-1269.
9. Hussein NR: The association of dupA and Helicobacter pylori-related
gastroduodenal diseases. Eur J Clin Microbiol Infect Dis 2010, 29(7):817-821.
10. Gomes LI, Rocha GA, Rocha AM, Soares TF, Oliveira CA, Bittencourt PF,
Queiroz DM: Lack of association between Helicobacter pylori infection
with dupA-positive strains and gastroduodenal diseases in Brazilian
patients. Int J Med Microbiol 2008, 298(3-4):223-230.
11. Argent RH, Burette A, Miendje Deyi VY, Atherton JC: The presence of dupA
in Helicobacter pylori is not significantly associated with duodenal
ulceration in Belgium, South Africa, China, or North America. Clin Infect
Dis 2007, 45(9):1204-1206.
12. Chang YT, Wu MS, Shun CT, Lin MT, Chang MC, Lin JT: Association of
polymorphisms of interleukin-1 beta gene and Helicobacter pylori
infection with the risk of gastric ulcer. Hepatogastroenterology 2002,
49(47):1474-1476.
13. Visse R, Nagase H: Matrix metalloproteinases and tissue inhibitors of
metalloproteinases: structure, function, and biochemistry. Circ Res 2003,
92(8):827-839.
14. Yeh YC, Sheu BS, Cheng HC, Wang YL, Yang HB, Wu JJ: Elevated serum
matrix metalloproteinase-3 and -7 in H. pylori-related gastric cancer can
be biomarkers correlating with a poor survival. Dig Dis Sci 2010,
55(6):1649-1657.
15. Mori N, Sato H, Hayashibara T, Senba M, Geleziunas R, Wada A, Hirayama T,
Yamamoto N: Helicobacter pylori induces matrix metalloproteinase-9
through activation of nuclear factor kappaB. Gastroenterology 2003,
124(4):983-992.
16. Crawford HC, Krishna US, Israel DA, Matrisian LM, Washington MK, Peek RM
Jr: Helicobacter pylori strain-selective induction of matrix
Table 4 Risks of combined MMP-3/TIMP-1 genotype for developing duodenal ulcer in females
Gastritis Duodenal ulcer OR (95% CI) P
MMP-3-1612- TIMP-1372 n (%) n (%)
5A carrier - T carrier 39 (88.6) 5 (11.4) 1 -
5A carrier - C/C 7 (77.8) 2 (22.2) 2.23 (0.36 - 13.85) 0.59
6A/6A - T carrier 109 (75.2) 36 (24.8) 2.58 (0.94 - 7.03) 0.06
6A/6A - C/C 28 (68.3) 13 (31.7) 3.62 (1.16 - 11.32) 0.03
The p value was determined by Fisher’s exact test. OR, odds ratio; 95% CI, 95% confidence interval.
Yeh et al. BMC Microbiology 2010, 10:218
http://www.biomedcentral.com/1471-2180/10/218
Page 7 of 8metalloproteinase-7 in vitro and within gastric mucosa. Gastroenterology
2003, 125(4):1125-1136.
17. Hellmig S, Ott S, Rosenstiel P, Robert Folsch U, Hampe J, Schreiber S:
Genetic variants in matrix metalloproteinase genes are associated with
development of gastric ulcer in H. pylori infection. Am J Gastroenterol
2006, 101(1):29-35.
18. Jormsjo S, Whatling C, Walter DH, Zeiher AM, Hamsten A, Eriksson P: Allele-
specific regulation of matrix metalloproteinase-7 promoter activity is
associated with coronary artery luminal dimensions among
hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 2001,
21(11):1834-1839.
19. Ye S, Eriksson P, Hamsten A, Kurkinen M, Humphries SE, Henney AM:
Progression of coronary atherosclerosis is associated with a common
genetic variant of the human stromelysin-1 promoter which results in
reduced gene expression. J Biol Chem 1996, 271(22):13055-13060.
20. Shipley JM, Doyle GA, Fliszar CJ, Ye QZ, Johnson LL, Shapiro SD, Welgus HG,
Senior RM: The structural basis for the elastolytic activity of the 92-kDa
and 72-kDa gelatinases. Role of the fibronectin type II-like repeats. J Biol
Chem 1996, 271(8):4335-4341.
21. Clark IM, Swingler TE, Sampieri CL, Edwards DR: The regulation of matrix
metalloproteinases and their inhibitors. Int J Biochem Cell Biol 2008,
40(6-7):1362-1378.
22. Sheu BS, Sheu SM, Yang HB, Huang AH, Wu JJ: Host gastric Lewis
expression determines the bacterial density of Helicobacter pylori in
babA2 genopositive infection. Gut 2003, 52(7):927-932.
23. Dixon MF, Genta RM, Yardley JH, Correa P: Classification and grading of
gastritis. The updated Sydney System. International Workshop on the
Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996,
20(10):1161-1181.
24. Shibata N, Ohnuma T, Higashi S, Usui C, Ohkubo T, Kitajima A, Ueki A,
Nagao M, Arai H: Genetic association between matrix metalloproteinase
MMP-9 and MMP-3 polymorphisms and Japanese sporadic Alzheimer’s
disease. Neurobiol Aging 2005, 26(7):1011-1014.
25. Zhou Y, Yu C, Miao X, Tan W, Liang G, Xiong P, Sun T, Lin D: Substantial
reduction in risk of breast cancer associated with genetic
polymorphisms in the promoters of the matrix metalloproteinase-2 and
tissue inhibitor of metalloproteinase-2 genes. Carcinogenesis 2004,
25(3):399-404.
26. Wollmer MA, Papassotiropoulos A, Streffer JR, Grimaldi LM, Kapaki E,
Salani G, Paraskevas GP, Maddalena A, de Quervain D, Bieber C, et al:
Genetic polymorphisms and cerebrospinal fluid levels of tissue inhibitor
of metalloproteinases 1 in sporadic Alzheimer’s disease. Psychiatr Genet
2002, 12(3):155-160.
27. Bullard KM, Mudgett J, Scheuenstuhl H, Hunt TK, Banda MJ: Stromelysin-1-
deficient fibroblasts display impaired contraction in vitro. J Surg Res
1999, 84(1):31-34.
28. Saarialho-Kere UK: Patterns of matrix metalloproteinase and TIMP
expression in chronic ulcers. Arch Dermatol Res 1998, 290(Suppl):S47-54.
29. Madlener M: Differential expression of matrix metalloproteinases and
their physiological inhibitors in acute murine skin wounds. Arch Dermatol
Res 1998, 290(Suppl):S24-29.
30. Tomita M, Ando T, Minami M, Watanabe O, Ishiguro K, Hasegawa M,
Miyake N, Kondo S, Kato T, Miyahara R, et al: Potential role for matrix
metalloproteinase-3 in gastric ulcer healing. Digestion 2009, 79(1):23-29.
doi:10.1186/1471-2180-10-218
Cite this article as: Yeh et al.: Matrix metalloproteinase-3 promoter
polymorphisms but not dupA-H. pylori correlate to duodenal ulcers in H.
pylori-infected females. BMC Microbiology 2010 10:218. Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Yeh et al. BMC Microbiology 2010, 10:218
http://www.biomedcentral.com/1471-2180/10/218
Page 8 of 8